Concepedia
Statistics
Publications
10
Citations
496
H-Index
Active since
2007
Affiliations
Texas Tech University Health Sciences Center(Current)
Texas Tech University
University of Cincinnati Medical Center
Dana-Farber Cancer Institute
University of Cincinnati
Nikhil Vad is an author at Texas Tech University Health Sciences Center specializing in pharmacology, oncology, and medicine.
Publications per year
2007–2016
Pharmacologic screens reveal metformin that suppresses GRP78-dependent autophagy to enhance the anti-myeloma effect of bortezomib
Sajjeev Jagannathan, M A Y Abdel-Malek, Ehsan Malek et al. · Leukemia · 2015 · 112 citations · Full text
Life Sciences, Oncology, Pharmacology +17
MiR-29b replacement inhibits proteasomes and disrupts aggresome+autophagosome formation to enhance the antimyeloma benefit of bortezomib
Sajjeev Jagannathan, Nikhil Vad, Sivakumar Vallabhapurapu et al. · Leukemia · 2014 · 78 citations · Full text
Medicine, Oncology, Pharmacology +17
Efficacy of Caffeic Acid Phenethyl Ester (CAPE) in skin B16-F0 melanoma tumor bearing C57BL/6 mice
Shashi Kudugunti, Nikhil Vad, Ehi Ekogbo et al. · Investigational New Drugs · 2009 · 65 citations
Medicine, Oncology, Pharmacology +10
Biochemical mechanism of Caffeic Acid Phenylethyl Ester (CAPE) selective toxicity towards melanoma cell lines
Shashi Kudugunti, Nikhil Vad, Amanda J. Whiteside et al. · Chemico-Biological Interactions · 2010 · 58 citations
Pharmacogenomics and chemical library screens reveal a novel SCFSKP2 inhibitor that overcomes Bortezomib resistance in multiple myeloma
Ehsan Malek, M A Y Abdel-Malek, Sajjeev Jagannathan et al. · Leukemia · 2016 · 56 citations · Full text
1–5 of 10